Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials Sasha MazzarelloBrian HuttonMark Clemons Review 24 May 2015 Pages: 1 - 8
Systematic review of effects of pregnancy on breast and abdominal contour after TRAM/DIEP breast reconstruction in breast cancer survivors Sadaf AlipourAmirhossein Eskandari Review 06 June 2015 Pages: 9 - 15
Inhibition of breast cancer cell migration by activation of cAMP signaling Hongli DongKevin P. ClaffeyPaul M. Epstein Preclinical study 29 May 2015 Pages: 17 - 28
Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer Zhike ChenYate-Ching YuanShiuan Chen Preclinical study 31 May 2015 Pages: 29 - 39
Inhibition of SDF-1/CXCR4-induced epithelial–mesenchymal transition by kisspeptin-10 Carsten GründkerGerd BauerschmitzGünter Emons Preclinical study 11 June 2015 Pages: 41 - 50
Detection and prevalence of disseminated tumor cells from the bone marrow of early stage male breast cancer patients Andreas D. HartkopfFlorin-Andrei TaranSara Y. Brucker Clinical trial 27 May 2015 Pages: 51 - 55
Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer Andrea RoccaAlberto FarolfiDino Amadori Clinical trial 27 May 2015 Pages: 57 - 65
Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients Christof VulstekeAlena M. PfeilHans Wildiers Clinical trial 28 May 2015 Pages: 67 - 76
Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02) Yeon Hee ParkKyung Hae JungYoung-Hyuck Im Clinical trial 02 June 2015 Pages: 77 - 85
Tumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography Pål MøllerKukatharmini TharmaratnamD. Gareth Evans Clinical Trial Open access 03 June 2015 Pages: 87 - 94
A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer Daniele GeneraliSergio VenturiniRosanna Tarricone Clinical Trial 05 June 2015 Pages: 95 - 117
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients Lisette BinkhorstJacqueline S. L. KlothRon H. J. Mathijssen Clinical Trial Open access 07 June 2015 Pages: 119 - 128
HBOC multi-gene panel testing: comparison of two sequencing centers Christopher SchroederUlrike FaustAndreas Rump Epidemiology 29 May 2015 Pages: 129 - 136
Adjuvant taxane-based chemotherapy for early stage breast cancer: a real-world comparison of chemotherapy regimens in Ontario Sofia TorresMaureen TrudeauKelvin K. W. Chan Epidemiology 31 May 2015 Pages: 137 - 145
Serum 25-hydroxyvitamin D deficiency and increased risk of breast cancer among Korean women: a case–control study Seho ParkDong Hoon LeeByeong-Woo Park Epidemiology 03 June 2015 Pages: 147 - 154
The proportion of postmenopausal breast cancer cases in the Netherlands attributable to lifestyle-related risk factors W. A. van GemertC. I. LantingS. G. Elias Epidemiology Open access 05 June 2015 Pages: 155 - 162
Doxorubicin-induced cardiac dysfunction in unselected patients with a history of early-stage breast cancer Megan E. V. CaramCui GuoJennifer J. Griggs Epidemiology 07 June 2015 Pages: 163 - 172
The association between breast cancer and thyroid cancer: a meta-analysis Kyle R. JosephSenarath EdirimanneGuy D. Eslick Epidemiology 10 June 2015 Pages: 173 - 181
Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes Yan LiuQiuyin CaiXiao-Ou Shu Epidemiology 11 June 2015 Pages: 183 - 191
Assessing absolute changes in breast cancer risk due to modifiable risk factors Anne S. QuanteJulia HerzMary Beth Terry Brief Report 27 May 2015 Pages: 193 - 197
Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer Lei ZhangXinyun SongHuiqing Cao Brief Report 02 June 2015 Pages: 199 - 208
Effect of lymph node metastasis size on breast cancer-specific and overall survival in women with node-positive breast cancer Brent S. RoseWei JiangRinaa S. Punglia Brief Report 04 June 2015 Pages: 209 - 216
Benefits and risks of contralateral prophylactic mastectomy in women undergoing treatment for sporadic unilateral breast cancer: a decision analysis Nataniel H. Lester-CollJanie M. LeeRobert G. Prosnitz Brief Report 11 June 2015 Pages: 217 - 226
Letter to the Editor Re: Bundred et al. “Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancer” Leigh C. WardSharon L. KilbreathElizabeth Dylke Letter to the Editor 15 May 2015 Pages: 227 - 228
Absence of the FANCM c.5101C>T mutation in BRCA1/2-negative triple-negative breast cancer patients from Pakistan Muhammad U. RashidNoor MuhammadUte Hamann Letter to the Editor 12 June 2015 Pages: 229 - 230